生殖医学杂志

参考文献

[1] Teede HJ,Tay CT,Laven J,et al.Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome[J].Eur J Endocrinol,2023,189:G43-G64.

[2] Wang L,Wen X,Lv S,et al.Comparison of endometrial receptivity of clomiphene citrate versus letrozole in women with polycystic ovary syndrome:a randomized controlled study[J].Gynecol Endocrinol,2019,35:862-865.

[3] Nikbakht R,Mohammadjafari R,Rajabalipour M,et al.Evaluation of oocyte quality in polycystic ovary syndrome patients undergoing ART cycles[J].Fertil Res Pract,2021,7:2.

[4] Bellemare V,Rotshenker-Olshinka K,Nicholls L,et al.Among high responders,is oocyte development potential different in Rotterdam consensus PCOS vs non-PCOS patients undergoing IVF?[J].J Assist Reprod Genet,2022,39:2311-2316.

[5] Matsuyama S,Whiteside S,Li SY.Implantation and decidualization in PCOS:unraveling the complexities of pregnancy[J].Int J Mol Sci,2024,25:1203.

[6]向金凤，王一枭，吴承倩，等．不孕症患者子宫内膜容受性异常的影响因素研究进展[J]．山东医药，2024,64:103-107.

[7] Chen Z,Dean M.Endometrial glucose metabolism during early pregnancy[J].Reprod Fertil,2023,4:e230016.

[8] Fornes R,Ormazabal P,Rosas C,et al.Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia[J].Mol Med,2010,16:129-136.

[9] Zhao D,Qu Q,Dai H,et al.Effects of hypoxia-inducible factor-1αon endometrial receptivity of women with polycystic ovary syndrome[J].Mol Med Rep,2018,17:414-421.

[10] Wang C,Wen YX,Mai QY.Impact of metabolic disorders on endometrial receptivity in patients with polycystic ovary syndrome[J].Exp Ther Med,2022,23:221.

[11]李红丽，严烩利．育龄期多囊卵巢综合征患者糖代谢与性激素及子宫内膜容受性的关系[J]．实用临床医药杂志，2024,28:106-111.

[12]李楠，陈蕾，许天敏，等．子宫内膜异位症患者细胞外基质相关基因筛选的生物信息学分析[J]．吉林大学学报（医学版），2022,48:188-194.

[13]王文娟，郑爱燕，高靓，等．血脂水平对排卵障碍患者冻融胚胎移植妊娠结局的影响[J]．生殖医学杂志，2024,33:1557-1563.

[14]张园，文彩荷，夏心如，等．接受供卵的不孕症患者血脂异常对临床结局的影响[J]．中华妇产科杂志，2022,57:686-691.

[15]马丽娜，秦莹，王克华，等．脂质代谢对子宫内膜容受性及胚胎着床影响的研究进展[J]．解放军医学杂志，2024,49:1088-1093.

[16] Jiang Y,Qi J,Xue X,et al.Ceramide subclasses identified as novel lipid biomarker elevated in women with polycystic ovary syndrome:apilot study employing shotgun lipidomics[J].Gynecol Endocrinol,2020,36:508-512.

[17]郝静茹，窦真，赵晓丽，等．多囊卵巢综合征脂质代谢异常对子宫内膜容受性影响的研究进展[J]．实用妇科内分泌电子杂志，2024,11:35-37.

[18]刘音，鲁娣，宋殿荣．胰岛素抵抗对多囊卵巢综合征生殖内分泌及代谢的影响[J]．国际妇产科学杂志，2023,50:190-195.

[19] Huh JY,Park YJ,Ham M,et al.Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity[J].Mol Cells,2014,37:365-371.

[20] Yang H,Youm YH,Vandanmagsar B,et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity:implications for systemic inflammation and insulin resistance[J].J Immunol,2010,185:1836-1845.

[21] Nishimura S,Manabe I,Nagasaki M,et al.CD8+effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity[J].Nat Med,2009,15:914-920.

[22] Han JM,Patterson SJ,Speck M,et al.Insulin inhibits IL-10-mediated regulatory T cell function:implications for obesity[J].J Immunol,2014,192:623-629.

[23] Eskandari Z,Sadrkhanlou RA,Nejati V,et al.PCOS women show significantly higher homocysteine level,independent to glucose and E2level[J].Int J Reprod Biomed,2016,14:495-500.

[24] Yang X,Tian X,Liu H,et al.Homocysteine increases uterine artery blood flow resistance in women with pregnancy loss[J].J Gynecol Obstet Hum Reprod,2023,52:102533.

[25]中华预防医学会生育力保护分会生殖内分泌生育保护学组．多囊卵巢综合征合并胰岛素抵抗诊治专家共识[J]．生殖医学杂志，2024,33:1133-1140.

[26]孟冉．子宫内膜厚度与子宫内膜整合素αVβ3及雌、孕激素受体相关性研究[D]．石家庄：河北医科大学，2022.

[27] Tang ZR,Zhang R,Lian ZX,et al. Estrogen-receptor expression and function in female reproductive disease[J].Cells,2019,8:1123.

[28]孙家珍，潘瑞洋，申素芳．宫腔灌注人绒毛膜促性腺激素改善多囊卵巢综合征患者子宫内膜容受性[J]．基础医学与临床，2020,40:496-500.

[29] Cloke B,Christian M. The role of androgens and the androgen receptor in cycling endometrium[J]. Mol Cell Endocrinol,2012,358:166-175.

[30] Abdul Hamid F,Abu MA,Abdul Karim AK,et al.Sex steroid receptors in polycystic ovary syndrome and endometriosis:insights from laboratory studies to clinical trials[J].Biomedicines,2022,10:1705.

[31] Younas K,Quintela M,Thomas S,et al.Delayed endometrial decidualisation in polycystic ovary syndrome;the role of ARMAGEA11[J].J Mol Med(Berl),2019,97:1315-1327.

[32] Apparao KB,Lovely LP,Gui Y,et al.Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome[J].Biol Reprod,2002,66:297-304.

[33] Choi HJ,Chung TW,Park MJ,et al.Water-extracted tubers of Cyperusrotundus L.enhance endometrial receptivity through leukemia inhibitory factor-mediated expression of integrinαVβ3andαVβ5[J].J Ethnopharmacol,2017,208:16-23.

[34]薛小梅，李淑馨，贺静，等．复发性流产孕妇孕早期子宫动脉血流参数与妊娠结局的相关性分析[J]．中国计划生育和妇产科，2022,14:58-61.

[35]陈秋梅．彩色多普勒血流成像在反复自然流产患者子宫内膜容受性评价中的应用分析[J]．中国医疗器械信息，2024,30:110-112.

[36] Ramidi G,Khan N,Glueck CJ,et al.Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss[J].Transl Res,2009,153:33-43.

[37]王丽，吕淑兰，毛文军，等．多囊卵巢综合征患者子宫内膜容受性和妊娠率分析[J]．山西医科大学学报，2020,51:577-581.

[38]向玉，杨惠林，马英兰，等．子宫内膜螺旋动脉血流参数与多囊卵巢综合征不孕症的关系及对体外受精-胚胎移植助孕妊娠结局的判断价值研究[J]．临床和实验医学杂志，2023,22:1643-1646.

[39] Chen W,Yang Q,Hu L,et al.Shared diagnostic genes and potential mechanism between PCOS and recurrent implantation failure revealed by integrated transcriptomic analysis and machine learning[J].Front Immunol,2023,14:1175384.

[40]周佳慧，杨贵芳，任杰，等．子宫内膜容受性的调节机制研究进展[J]．生殖医学杂志，2024,33:1395-1400.

[41] Li B,Duan H,Wang S,et al.Establishment of an artificial neural network model using immune-infiltration related factors for endometrial receptivity assessment[J].Vaccines(Basel),2022,10:139.

[42] Von Woon E,Greer O,Shah N,et al.Number and function of uterine natural killer cells in recurrent miscarriage and implantation failure:a systematic review and meta-analysis[J].Hum Reprod Update,2022,2:548-582.

[43]王琪，季小忠．多巢囊肿综合征不孕患者血NK细胞、CD8+Tc细胞和Th1/Th2与性激素水平关系[J]．中国计划生育学杂志，2021,29:1689-1692.

[44]陈佳媛，倪天翔，颜军昊．PCOS患者子宫内膜容受性缺陷研究进展[J]．中华生殖与避孕杂志，2024,44:1021-1026.

[45]陈思琦，刘佳佳，崔鲂．富血小板血浆治疗对胚胎反复植入失败患者外周血Th1、Th2型细胞因子水平及妊娠结局的影响[J]．中国医刊，2023,58:806-809.

[46] Samy N,Hashim M,Sayed M,et al.Clinical significance of inflammatory markers in polycystic ovary syndrome:their relationship to insulin resistance and body mass index[J].Dis Markers,2009,26:163-170.

[47] Hoesel B,Schmid JA.The complexity of NF-κB signaling in inflammation and cancer[J].Mol Cancer,2013,12:86.

[48] Hu M,Zhang Y,Guo X,et al.Perturbed ovarian and uterine glucocorticoid receptor signaling accompanies the balanced regulation of mitochondrial function and NFκB-mediated inflammation under conditions of hyperandrogenism and insulin resistance[J].Life Sci,2019,232:116681.

[49] Díaz-Gimeno P,Horcajadas JA,Martínez-Conejero JA,et al.A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature[J].Fertil Steril,2011,95:50-60.e15.

[50] Carosso A,Revelli A,Gennarelli G,et al.Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles:apilot study[J].J Assist Reprod Genet,2020,37:2315-2326.

[51] Moreno I,Garcia-Grau I,Perez-Villaroya D,et al.Endometrial microbiota composition is associated with reproductive outcome in infertile patients[J].Microbiome,2022,10:1.

[52] Cariati F,Carotenuto C,Bagnulo F,et al.Endometrial microbiota profile in in-vitro fertilization(IVF)patients by culturomics-based analysis[J].Front Endocrinol(Lausanne),2023,14:1204729.

[53] Wang J,Li Z,Ma X,et al. Translocation of vaginal microbiota is involved in impairment and protection of uterine health[J].Nat Commun,2021,12:4191.

[54]王荣，陈秀娟．生殖道微生物对子宫内膜容受性及体外受精-胚胎移植术妊娠结局的影响[J]．中国医药科学，2024,14:29-32.

[55]秦晶晶，唐振利，孙鸿博，等．PCOS孕妇孕晚期阴道微生物分布特点与妊娠结局的关系分析[J]．中国妇产科临床杂志，2023,24:274-277.

[56]姚盼盼，韩延华，姜玥，等．肠道菌群对多囊卵巢综合征胰岛素抵抗的影响及治疗研究进展[J]．辽宁中医药大学学报，2025,27:89-94.

[57]石百超，常惠，王宇，等．肠道菌群在多囊卵巢综合征中的作用机制[J]．国际生殖健康/计划生育杂志，2024,43:238-243.

[58]张娟娟，王景龙．基于肠道菌群探讨多囊卵巢综合征的发病机制及中医药干预研究进展[J]．中医药学报，2024,52:92-97.

[59]王奕心，巩志国，代佳山，等．普雷沃氏菌对肠道菌群失调所致小鼠子宫组织损伤的保护作用[J]．微生物学通报[2025-02-21].https：//doi.org/10.13344/j.microbiol.china.250001.

[60] He F,Li Y.The gut microbial composition in polycystic ovary syndrome with insulin resistance:findings from a normal-weight population[J].J Ovarian Res,2021,14:50.

[61] Zeng B,Lai Z,Sun L,et al.Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance(IR-PCOS):apilot study[J].Res Microbiol,2019,170:43-52.

[62] B?ckhed F,Ding H,Wang T,et al.The gut microbiota as an environmental factor that regulates fat storage[J].Proc Natl AcadSci U S A,2004,101:15718-15723.

[63]方洁，刘海燕．肠道菌群与多囊卵巢综合征发生发展的研究进展[J]．生殖医学杂志，2024,33:396-400.